title: Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.
authors.forename: James L
authors.initials: JL
authors.lastname: Karagianis
authors.forename: Eduardo
authors.initials: E
authors.lastname: Dunayevich
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D015982:Bias; D015415:Biomarkers / Q000097:blood*; D003324:Coronary Artery Disease / Q000378:metabolism*; D003430:Cross-Sectional Studies; D005215:Fasting / Q000097:blood / Q000378:metabolism; D006801:Humans; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000378:metabolism*; D000077152:Olanzapine; D012107:Research Design / Q000592:standards; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D015415:Biomarkers; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine